Test 3 Flashcards
What are the effects of the following on vasculature? Where do they come from? TXA2 ADP Thromboplastin (TF3) Plasmin PGI2 Nitric Oxide Endothelin-1 Thrombomodulin tPA
TXA2: released by platelets, facilitates platelet aggregation
ADP: released by platelets, facilitates platelet aggregation by binding to P2y receptors
Thromboplastin (TF): released by activated platelets and injured endothelial cells,
Plasmin: released by activated platelets?
PGI2: released by uninjured endothelial cells as vasodilator, working against platelet aggregation
Nitric Oxide: released by uninjured endothelial cells as vasodilator, working against platelet aggregation
Endothelin-1: released from injured endothelial cells, causes vasoconstriction
Thrombomodulin: expressed on injured endothelial cells, activates Protein C by helping Thrombin
tPA: released from endothelial cells, converts plasminogen to plasmin
Where are the following drugs site of action? Aspirin ClopidoGREL, TicaGRELor Abciximab, Eptifibatide, Tirofiban Vorapaxar
Aspirin: blocks COX1
ClopidoGREL, TicGRELor: blocks ADP receptor
Abciximab, Eptifibatide, Tirofiban: blocks IIb-IIIa receptor
Vorapaxar: blocks thrombin receptor
What must happen to Vit K before it can be integrated into the coagulation cycle? Then what does it do?
Vit K must be reduced by Vit K reductase
then it helps Vit K dependent clotting factors undergo carboxylation to get activated
What CFs are Vit K dependent? anything else?
CF II, VII, IX, X
Protein C and S
What does Thrombin activate?
Thrombin (II) activates: 5, 8 ((normally circulating in blood bound to vWF, thrombin cleaves it), 11, 13 Fibrinogen → Fibrin Protein C → activated PC platelets by binding to PAR-1
What are the 5 elements in the prothrombinase complex
Prothrombinase Complex 1 Ca 2 Activated phospholipid membrane 3 Factor Xa 4 Factor Va 5 Prothrombin
Walk through steps of fibrinolysis
Fibronilysis:
Endothelial cells replease tPA
tPA converts Plasminogen to Plasmin (after plasminogen’s bound to fibrin)
Plasmin cleaves Fibrin
What are the drugs that act on the following sites? blocks COX1 blocks ADP receptor blocks IIb-IIIa receptor blocks thrombin receptor
Aspirin: blocks COX1
ClopidoGREL: blocks ADP receptor
Abciximab, Eptifibatide, Tirofiban: blocks IIb-IIIa receptor
Vorapaxar: blocks thrombin receptor
What are 7 ways blood clotting is controlled?
1: factor activation restricted to activated platelets or damaged endothelium
2: Antithrombin III circulates and inhibits Thombin and Factors 9-12
3: Endothelial thrombomodulin binds and inactivates Thrombin
4: Protein C+S inactivated Factors 5 and 8
5: Endothelial secretion of Tissue Factor Pathway Inhibitor (TFPI) inactivates Factor 10/5 and 9/8 complexes
6: Endothelial secretion of NO and PGI2 inhibit platelet aggregation
7: Endothelial secretion of tPA
What’s genetic etiology (and mutation), pathophysiology, and clinical presentation for Antithrombin deficiency?
How does it present if Complete AT Deficiency?
genetics: AD for serine protease mutation in Antithrombin that reduces AT activity
Pathophys: Serine protease normally inhibits Factors 9, 10, 11, 12, and 2 (Thrombin)
clinical: DVT, mesenteric vein thrombosis, and recurrent thrombotic episodes by 40yo
Complete AT Deficiency = fatal
What’s genetic etiology (and mutation), pathophysiology, and clinical presentation for Factor V Leiden?
Which populations see a prevalence?
Genetics: AD, G→A Arg506Gln point mutation in Factor 5’s aProteinC cleavage site
Pathophys: Factor V can’t be cleaved
Clinical: risk DVT and pregnancy loss, decreased susceptibility to spesis and bleeding and PEs
Caucasian/Greek prevalence
What’s genetic etiology (and mutation), pathophysiology, and clinical presentation for Prothrombin gene mutation?
Genetics: AD, mRNA accumulation of G20210A mutation leads to increased translation and prothrombin (Factor 2) levels)
Pathophys: Increased levels of Prothrombin aka Factor 2
Clinical: risk venous thrombosis
Differentiate MOA of Heparin, LMWH, and Fondaparinux
Heparin: binds w/ATIII to inactivate Thrombin and Factors 9-12
LMWH: binds w/ATIII to inactivate Factor 10
Fondaparinux: indirect Factor 10 inhibitor
How do you reverse Heparin, LMWH, Fondaparinux?
Direct Factor 10 inhibitors Rivaroxaban/Apixaban, Warfarin, Direct Thrombin inhibitors Dabigatran/Argatroban/Bivalirudin?
Heparin: Protamine
LMWH: Protamine, but RecombFactor 7a is more effective
Fondaparinux: RecombFactor7
Rivaroxaban/Apixaban: can’t
Warfarin: Vit K
Dabigatron/Argatroban/Bivalirudin: Idarucizumab
Rivaroxaban/Apixaban, and Dabigatran/Argatroban/Bivalirudin MOA?
Rivaroxaban, Apixaban = Direct Factor 10 block
Dabigatran, Argatroban, Bivalirudin = Direct Thrombin (Factor 2) and Factor 10 block
What are the 2 Factor 10a inhibitors drugs?
What’s the 3 Direct Thrombin inhibitor drugs?
Factor 10a inhibitor: Rivaroxaban, Apixaban
Direct Thrombin inhibitors: Dabigatran, Argatroban, Bivalirudin
What’s the most common inherited hypercoaguable disease?
most common aquired hypercoaguable?
most common inherited hemophilia disease?
most common drug-induced thrombocytopenia in adults?
Inherited Hypercoaguable: Factor V Leiden
Acquired Hypercoaguable: Antiphospholipid Ab syndrome
Inherited Hemophilia: vWD
Drug induced thrombocytopenia: HIT (heparin induced thrombocytopenia)
Differentiate ITP and HIT
Immune Thrombocytopenic Purpura: Abs target GP IIb/IIIa (usually, rarely Ib/9), bind to Fc receptors on macrophages
HIT: body makes Ab to Heparin+Factor4, Abs bind to platelets, splenic macrophages remove platelets
Differentiate vWD and Glanzmann’s thrombasthenia
vWD: vWF defect, doesn’t allow platelets to clot appropriately
Glanzmann’s thrombasthenia: GPIIb/IIIa defect
How can you treat ITP?
ITP tx: steroids IV IgG to compete w/macrophage activity against IGs splenectomy immunosuppression